Advertisement
PARIS, France—Implantation of bioresorbable vascular scaffolds (BVS) appears feasible and safe in select patients with acute ST segment elevation myocardial…
PARIS, France—A novel, biodegradable-polymer, sirolimus-eluting stent designed to treat bifurcation lesions demonstrates positive angiographic and…
PARIS, France—Two studies exploring new methods of delivering paclitaxel to treat peripheral artery disease (PAD) were presented Tuesday, May 21, at…
PARIS, France—Use of 4-Fr devices is feasible for the majority of endovascular interventions, achieving similar technical success and primary patency…
PARIS, France—A biodegradable-polymer drug-eluting stent has proven noninferior to a durable-polymer device in terms of late lumen loss at 9 months,…
PARIS, France—A fully bioresorbable drug-eluting stent (DES) shows low late lumen loss and good safety results at 6 months in patients with de novo…
For patients with bifurcation lesions, the new dual-stent modified “flower petal” technique offers several advantages over available stenting options,…
Compared with standard evaluation, which often includes nothing but observation and discharge, use of coronary computed tomographic angiography (CTA)…
In patients with acute intracranial large-vessel occlusions, endovascular therapy reduces final infarct size more than either intravenous tissue plasminogen…
In patients undergoing transcatheter aortic valve replacement (TAVR), a dual-filter embolic protection device enables the capture of debris traveling…
Oxygen administration prior to elective angiography or percutaneous coronary intervention (PCI) reduces contrast induced nephropathy (CIN), according…
At 4 years, patients with mitral valve regurgitation who undergo repair with a novel percutaneous device experience mortality rates and mitral regurgitation…